GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (HAM:OC5) » Definitions » Cyclically Adjusted Price-to-FCF

Cochlear (HAM:OC5) Cyclically Adjusted Price-to-FCF : 121.39 (As of Jun. 07, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Cochlear Cyclically Adjusted Price-to-FCF?

As of today (2024-06-07), Cochlear's current share price is €200.30. Cochlear's Cyclically Adjusted FCF per Share for the fiscal year that ended in Jun23 was €1.65. Cochlear's Cyclically Adjusted Price-to-FCF for today is 121.39.

The historical rank and industry rank for Cochlear's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

HAM:OC5' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 38.79   Med: 84.01   Max: 138.21
Current: 118.86

During the past 13 years, Cochlear's highest Cyclically Adjusted Price-to-FCF was 138.21. The lowest was 38.79. And the median was 84.01.

HAM:OC5's Cyclically Adjusted Price-to-FCF is ranked worse than
87.76% of 237 companies
in the Medical Devices & Instruments industry
Industry Median: 42.61 vs HAM:OC5: 118.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Cochlear's adjusted free cash flow per share data of for the fiscal year that ended in Jun23 was €2.505. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €1.65 for the trailing ten years ended in Jun23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cochlear Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Cochlear's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Cyclically Adjusted Price-to-FCF Chart

Cochlear Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.68 105.21 130.11 89.52 84.41

Cochlear Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 89.52 - 84.41 -

Competitive Comparison of Cochlear's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Cochlear's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cochlear's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Cochlear's Cyclically Adjusted Price-to-FCF falls into.



Cochlear Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Cochlear's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=200.30/1.65
=121.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cochlear's Cyclically Adjusted FCF per Share for the fiscal year that ended in Jun23 is calculated as:

For example, Cochlear's adjusted Free Cash Flow per Share data for the fiscal year that ended in Jun23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun23 (Change)*Current CPI (Jun23)
=2.505/124.1700*124.1700
=2.505

Current CPI (Jun23) = 124.1700.

Cochlear Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.960 98.352 1.212
201506 1.925 99.838 2.394
201606 1.698 100.859 2.090
201706 2.319 102.809 2.801
201806 2.321 104.945 2.746
201906 1.932 106.617 2.250
202006 -2.963 106.246 -3.463
202106 1.918 110.332 2.159
202206 3.025 117.112 3.207
202306 2.505 124.170 2.505

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cochlear  (HAM:OC5) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Cochlear Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Cochlear's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Cochlear (HAM:OC5) Business Description

Traded in Other Exchanges
Address
1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

Cochlear (HAM:OC5) Headlines

No Headlines